Le Lézard
Classified in: Health
Subject: FVT

Vial announces advisory board to discuss the "Future of Dermatology CROs" with leading sites at 2022 Winter Clinical Dermatology Conference

SAN FRANCISCO, Jan. 15, 2022 /PRNewswire/ -- Vial announces that in conjunction with the 2022 Winter Clinical Dermatology conference it will host an Advisory Board with leading research sites to discuss the challenges in clinical research with a focus on improving speed and quality of trials in Dermatology.

Launched earlier this year, under the tag line, "The CRO Built for Sponsors," the Vial Dermatology CRO promises higher quality and faster execution of trials powered by the Vial Clinic Network of over 35 Dermatology clinics across the country.

The Vial Dermatology CRO team is led by Betsey Zbyszynski as Head of Clinical Operations, Jason Shuris as Head of Sales, Janet DuBois, M.D. as Medical Director, Justin Withers as Head of Dermatology, and Mamta Hunt as Head of Quality. The CRO executive team joins Vial with over 100+ years of combined dermatology clinical trial experience.

The Vial executive team is attending the 2022 Winter Clinical dermatology conference to engage with sponsors leading the forefront of Dermatology research and top research sites.

The Vial CRO Advisory Board will discuss the the challenges facing Dermatology clinical research today, capture feedback on the Vial Dermatology CRO model, and engage the Dermatology community - sponsors, KOLs and leading sites - on improving trial quality and speed. The Vial executive team will incorporate the Advisory Board feedback from Dermatology research sites into the Vial Dermatology CRO strategy and release a whitepaper on the Vial.com website highlighting the feedback.

About Vial:

Vial's mission is to run clinical trials with faster execution and higher quality in order to bring new therapies to market. Vial has over 70 employees and is based in San Francisco, California. Vial partners with Dermatologists to support their research teams and has created a network of over 35 Dermatology clinics. The Vial network has contributed to over 150 trials for many of the leading sponsors in Dermatology having run trials across common Medical Dermatology indications (Atopic Dermatitis, Psoriasis, Vitiligo, Alopecia Areata, Rosacea, Hidradenitis Suppurativa, Prurigo Nodularis among others) as well as Cosmetic Dermatology indications. The clinic network runs trials from Phase I through Phase IV.

For more information on our Dermatology CRO


These press releases may also interest you

at 20:05
CANbridge Pharmaceuticals Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, today announced that it will...

at 19:00
Vanda Pharmaceuticals Inc. (Vanda) today announced participation at Digestive Disease Week (DDW) 2022, to be held in San Diego, CA and online from May 21-24, 2022. The following will be presented: May 21, 2022 Presentation Title: "THE ROLE OF M1 TO...

at 18:56
SEIU Healthcare, a union that represents 60,000 healthcare workers in the province of Ontario, has retained Ruby Shiller Enenajor DiGiuseppe (RSED) LLP to explore all legal options to defend union members who sustained injuries at Monday's leaders'...

at 18:38
Biogénesis Bagó, a global animal health biotechnology company, hosted a seminar in Jordan where it presented to government authorities, international organizations, producers and customers from 14 countries in the Middle East and North Africa, its...

at 18:35
Linamar Corporation today announced the formation of Linamar MedTech, a new medical manufacturing group which will focus on leveraging its expert capabilities in precision manufacturing to pursue opportunities in the Medical Device and Precision...

at 18:17
How do you mend a broken heart? With plastic. That's a goal at Tampa General Hospital, where a sophisticated 3D printing program is making replicas of human organs from layers of artificial materials. Teaming up with the USF Health Morsani College of...

News published on 15 january 2022 at 17:06 and distributed by: